Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Copper Peptide for Sale > Retatrutide 99% API raw material tissue repair peptides
Retatrutide  99% API raw material tissue repair peptides buy - large image1
Retatrutide  99% API raw material tissue repair peptides buy - image1
Retatrutide  99% API raw material tissue repair peptides buy - image2
Retatrutide  99% API raw material tissue repair peptides buy - image3
Retatrutide  99% API raw material tissue repair peptides buy - image4
Retatrutide  99% API raw material tissue repair peptides buy - image5
Retatrutide  99% API raw material tissue repair peptides buy - image6

Retatrutide 99% API raw material tissue repair peptides

150 Inquiries

Unit Price:

$10-11/G FOB

Get Latest Price
CAS No.:

49557-75-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ShenZhen

Brand:

No Brand

Packaging:

5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g

Price valid (until):

2026-10-09

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    FAQ

    Q1: Can I place a trial order for one vial?
    A: Yes, trial orders are acceptable.

    Q2: What payment terms do you support?
    A: We accept T/T, PayPal, bank transfer and other payment methods. Please pick the one most convenient for you.

    Q3: What is the lead time and shipping option?
    A: We ship by international couriers (DHL, UPS, FedEx) or air freight. Delivery time to your address is approximately 8‑10 business days.



      Product Detail  


    Shop Retatrutide  99% API raw material tissue repair peptides-Detailed Image 1
     
    Shop Retatrutide  99% API raw material tissue repair peptides-Detailed Image 2
    Shop Retatrutide  99% API raw material tissue repair peptides-Detailed Image 3
     Product Name Retatrutide Powder
    Name Retatrutide
    Type Lyophilized Powder
    storage Store in a cool and dark place
    CAS No 49557-75-7
    Purity ≥99%
    Specific 5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g
    Package 10 vials/box
    ECHEMI Editorial Reference
    Copper peptide GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. The tripeptide has strong affinity for copper(II) and was first isolated from human plasma. It can be found also in saliva and urine.
    ChEBI: Gly-His-Lys is a tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence. It has a role as a metabolite, a chelator, a vulnerary and a hepatoprotective agent.

    Basic Info
    Product Name:

    Copper Peptide

    Other Name:

    GHK Cu Copper Peptide;L-Lysine,glycyl-L-histidyl-;Copper Peptide powder (GHK-cu);GHK Cu Copper Peptide GHK.Cu GHK-Cu;Liver Cell Growth Factor(GHK);GHKcu/Growth-Modulating peptide;(Gly-His-Lys)2Cu.xHAc;AHK-Cu (Copper Peptide)

    CAS No.:

    49557-75-7

    Molecular Formula:

    C14H24N6O4

    InChIKeys:

    MVORZMQFXBLMHM-QWRGUYRKSA-N

    Molecular Weight:

    340.38

    EC Number:

    1592732-453-0

    Color/Form:

    Off-White

    Categories:

    Polypeptide

    Characteristics
    Density:

    1.324

    Melting Point:

    >144°C (dec.)

    Boiling Point:

    831.0±65.0 °C(Predicted)

    PKA:

    3.11±0.10(Predicted)

    Critical Temperature & Pressure:

    under inert gas (nitrogen or Argon) at 2–8 °C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

    Location:

    18 Linchang, Wujin district, Changzhou, China

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

    Company Profile

    HANGZHOU PLANOVO BIOTECH CO LTD. was officially established on August 25, 2016, at Linchang Group, Mandun Village, Jiaze Town, Wujin District, Changzhou, Jiangsu Province, China. As an innovative enterprise dedicated to the biotechnology sector, the company has quickly made its mark in the industry through outstanding R&D capabilities, rigorous quality control, and a diversified business portfolio, guided by its corporate philosophy of "Quality First, Customer Supreme, Innovation-driven, Integrity in Service."

    Business Scope

    The company's business covers a wide range of areas:

    • Biotechnology and Medical Device R&D Consulting: Focusing on frontier biotechnology research and driving the translation of scientific achievements into practical applications;

    • Cosmetics Production and Sales: Offering high-quality cosmetic products built on a mature R&D and manufacturing system;

    • Medical Device Manufacturing and Sales: Covering Class I, Class II, and Class III medical devices, strictly in accordance with the approved scope of relevant licenses.

    R&D Strength

    The company has an R&D team composed of senior researchers and professional technical talents who uphold the spirit of innovation and focus on R&D and consulting services in biotechnology and medical device technology. The team continuously explores cutting-edge technologies, dedicated to converting the latest scientific research results into practical applications and providing a steady stream of momentum for product innovation.

    Main Product: Tirzepatide/Retatrutide/Semaglutide/CBL-514/Peptide/GLP-1/GHK-CU/NAD+

  • Inquiry History
    150 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cosmetic Copper GhkCU Peptide CAS 49557-75-7 Peptide 50mg Ghk-Cu

    2 MT Nov 6, 2023
    Malaysia

    High quality 98% up Copper Peptide GHK-Cu powder CAS 49557-75-7

    1 KG Oct 19, 2023
    United States

    Copper Peptide 99% Copper Peptide Ghk-Cu Powder Ghk Cu CAS 49557-75-7

    1 KG Mar 26, 2026
    China

    Glycyl-l-histidyl-l-lysine

    10 KG Oct 24, 2023
    Sweden

    GHK-Cu

    1 KG Mar 17, 2026
    United States

    GHK-Cu Blue Copper Peptide

    100 MG Aug 31, 2026
    Brazil

    Ghk cu

    5 MT Aug 26, 2026
    China

    Ghk-Cu

    1 MT Aug 6, 2026
    United Kingdom

    ghk-cu

    100 MG Jul 23, 2026
    Brazil

    Ghk-cu

    30 MG Jul 14, 2026
    United States

    GHK-Cu

    100 MG Jul 13, 2026
    United States

    GHK-Cu

    1 G Jul 13, 2026
    United States

    GHK-CU

    5 MT Jul 12, 2026
    Brazil

    GHK-Cu

    50 MG Jul 9, 2026
    United States

    Ghost-cu

    200 MT Jul 6, 2026
    United Kingdom

    GHK-cu

    50 MG Jul 3, 2026
    United States

    Cooper peptide

    1 G Jun 30, 2026
    South Africa

    GHK-CU

    3 MG Jun 17, 2026
    United States

    GHK-CU

    1 MT Jun 13, 2026
    Canada

    Ghk-cu

    500 MG Jun 11, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.